Silencing Lyn kinase overcomes resistance to imatinib in Bcr-Abl-dependent CML cells

被引：0
|
作者：
Wu, Ji Yuan [1 ]
Talpaz, Moshe [1 ]
Donato, Nicholas J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2345
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Combination treatment of imatinib-sensitive and -resistant BCR-ABL-positive CML cells with imatinib and farnesyltransferase inhibitors
    Radujkovic, Aleksandar
    Topaly, Julian
    Fruehauf, Stefan
    Zeller, W. Jens
    ANTICANCER RESEARCH, 2006, 26 (3A) : 2169 - 2177
  • [42] BCR-ABL- and Ras-independent activation of Raf as a novel mechanism of Imatinib resistance in CML
    Hentschel, Julia
    Rubio, Ignacio
    Eberhart, Melanie
    Hipler, Christina
    Schiefner, Jana
    Schubert, Katrin
    Loncarevic, Ivan F.
    Wittig, Ute
    Baniahmad, Aria
    Von Eggeling, Ferdinand
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (03) : 585 - 591
  • [43] Bcr-Abl Inhibition by Imatinib Restores Lyn Trafficking to Lipid Rafts and Promotes CXCR4 Surface Expression of CML Cells in BM Microenvironment
    Tabe, Yoko
    Jin, Linhua
    Ichikawa, Naoki
    Konopleva, Marina
    Andreeff, Michael
    Miida, Takashi
    BLOOD, 2008, 112 (11) : 1094 - 1094
  • [44] Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels
    Gambacorti-Passerini, C
    Piazza, R
    D'Incalci, M
    BLOOD, 2003, 102 (05) : 1933 - 1934
  • [45] IM resistance of cml stem cells is BCR-ABL dependent and cannot be overcome by dose escalation in vitro
    Hamilton, A
    Elrick, LJ
    Allan, E
    Baird, JW
    Jorgensen, HG
    Holyoake, TL
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 105 - 105
  • [46] Determining the Rise in BCR-ABL RNA That Optimally Predicts a Kinase Domain Mutation in Patients with CML on Imatinib
    Press, Richard D.
    Willis, Stephanie G.
    Laudadio, Jennifer
    Mauro, Michael J.
    Deininger, Michael W. N.
    BLOOD, 2008, 112 (11) : 405 - 405
  • [47] Resistance to imatinib of Bcr/Abl p190 lymphoblastic leukemia cells
    Mishra, Suparna
    Zhang, Bin
    Cunnick, Jess M.
    Heisterkamp, Nora
    Groffen, John
    CANCER RESEARCH, 2006, 66 (10) : 5387 - 5393
  • [48] Expression of a Src-family kinase in CML cells induces resistance to imatinib in a kinase-dependent manner
    Pene-Dumitrescu, Teodora
    Smithgall, Thomas E.
    CANCER RESEARCH, 2010, 70
  • [49] BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI-571.
    Donato, NJ
    Wu, JY
    Stapley, J
    Gallick, GE
    Hui, L
    Arlinghaus, RB
    Talpaz, M
    BLOOD, 2002, 100 (11) : 371A - 371A
  • [50] AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
    Zhou, Liang L.
    Zhao, Yun
    Ringrose, Ashley
    DeGeer, Donna
    Kennah, Erin
    Lin, Ann E. -J.
    Sheng, Guoqing
    Li, Xiao-Jiang
    Turhan, Ali
    Jiang, Xiaoyan
    JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (11): : 2657 - 2671
12345